Literature DB >> 18385759

Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation.

Michael D Howell1, Heather R Fairchild, Byung Eui Kim, Lianghua Bin, Mark Boguniewicz, Jasmina S Redzic, Kirk C Hansen, Donald Y M Leung.   

Abstract

Atopic dermatitis (AD) is an inflammatory skin disease associated with frequent skin infection and impaired skin barrier function. Recent studies indicate that increased Th2 cytokine expression contributes to reduction in antimicrobial peptides and reduced filaggrin (FLG) expression, however, the mechanisms leading to this effect is unknown. Using proteomics, we found the S100 calcium-binding protein A11 (S100/A11) to be significantly downregulated in the presence of IL-4 and IL-13. Culturing keratinocytes with increased calcium concentrations significantly induced S100/A11 expression. This corresponded with an increase in human beta-defensin (HBD)-3 and FLG expression. Interference of S100/A11 expression, by siRNA, inhibited induction of HBD-3 and FLG. Furthermore p21, a cyclin-dependent kinase inhibitor downstream of S100/A11, was required for calcium-mediated induction of HBD-3 and FLG. Importantly, transduction of p21-recombinant protein into keratinocytes prevented IL-4/IL-13-mediated inhibition of FLG and HBD-3 expression. S100/A11 and p21 gene expression was also found to be significantly lower in acute and chronic AD skin. This study demonstrates an important role for S100/A11 and p21 in regulating skin barrier integrity and the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385759     DOI: 10.1038/jid.2008.74

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  65 in total

1.  Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases.

Authors:  Marie-Claire Méchin; Fanny Coudane; Véronique Adoue; Jacques Arnaud; Hélène Duplan; Marie Charveron; Anne-Marie Schmitt; Hidenari Takahara; Guy Serre; Michel Simon
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

Review 2.  Recent advances in the treatment of eosinophilic esophagitis.

Authors:  Shauna Schroeder; Dan Atkins; Glenn T Furuta
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

3.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

Review 4.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

Review 5.  Current insights into the role of human β-defensins in atopic dermatitis.

Authors:  P Chieosilapatham; H Ogawa; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

6.  Epidermal tight junctions in health and disease.

Authors:  J M Brandner; M Zorn-Kruppa; T Yoshida; I Moll; L A Beck; A De Benedetto
Journal:  Tissue Barriers       Date:  2015-04-03

7.  Esophageal human β-defensin expression in eosinophilic esophagitis.

Authors:  Shauna Schroeder; Zachary D Robinson; Joanne C Masterson; Lindsay Hosford; Wendy Moore; Zhaoxing Pan; Rachel Harris; Rhonda F Souza; Stuart Jon Spechler; Sophie A Fillon; Glenn T Furuta
Journal:  Pediatr Res       Date:  2013-02-05       Impact factor: 3.756

8.  CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.

Authors:  Dirkjan Hijnen; Edward F Knol; Yoony Y Gent; Barbara Giovannone; Scott J P Beijn; Thomas S Kupper; Carla A F M Bruijnzeel-Koomen; Rachael A Clark
Journal:  J Invest Dermatol       Date:  2012-12-06       Impact factor: 8.551

Review 9.  Post-genomics and skin inflammation.

Authors:  Daniela Braconi; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

10.  p300 alters keratinocyte cell growth and differentiation through regulation of p21(Waf1/CIP1).

Authors:  Ping-Pui Wong; Adam Pickard; Dennis J McCance
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.